Compare 3SBio, Inc. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Poor long term growth as Operating profit has grown by an annual rate 17.14% of over the last 5 years
- The company is Net-Debt Free
2
With ROE of 0.58%, it has a Very Expensive valuation with a 1.41 Price to Book Value
3
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-36.06%
0%
-36.06%
6 Months
-39.01%
0%
-39.01%
1 Year
-47.22%
0%
-47.22%
2 Years
144.33%
0%
144.33%
3 Years
122.45%
0%
122.45%
4 Years
188.39%
0%
188.39%
5 Years
89.78%
0%
89.78%
3SBio, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
16.10%
EBIT Growth (5y)
17.14%
EBIT to Interest (avg)
98.13
Debt to EBITDA (avg)
0.25
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.03
Tax Ratio
18.02%
Dividend Payout Ratio
6.57%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
17.46%
ROE (avg)
9.23%
Valuation key factors
Factor
Value
P/E Ratio
242
Industry P/E
Price to Book Value
1.41
EV to EBIT
201.57
EV to EBITDA
170.12
EV to Capital Employed
2.12
EV to Sales
41.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.05%
ROE (Latest)
0.58%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'14 - YoY
Dec'14
Dec'13
Change(%)
Net Sales
341.70
233.90
46.09%
Operating Profit (PBDIT) excl Other Income
99.10
40.60
144.09%
Interest
5.70
0.00
Exceptional Items
0.00
-0.70
100.00%
Consolidate Net Profit
90.30
22.50
301.33%
Operating Profit Margin (Excl OI)
258.20%
126.90%
13.13%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2014 is 46.09% vs 14.94% in Dec 2013
Consolidated Net Profit
YoY Growth in quarter ended Dec 2014 is 301.33% vs 6.13% in Dec 2013
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
19,191.50
9,875.10
94.34%
Operating Profit (PBDIT) excl Other Income
12,038.50
3,313.10
263.36%
Interest
82.80
206.90
-59.98%
Exceptional Items
275.40
-352.70
178.08%
Consolidate Net Profit
9,864.90
2,404.30
310.30%
Operating Profit Margin (Excl OI)
596.60%
290.20%
30.64%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 94.34% vs 14.34% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 310.30% vs 37.17% in Dec 2024
About 3SBio, Inc. 
3SBio, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






